Advanced search×

The binding activity of Mel-18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines.

Eur J Immunol 41(8):2424-35 (2011) PMID 21674483

We have previously shown that in differentiated T-helper (Th)1 and Th2 cells, polycomb group (PcG) proteins are associated differentially with the promoters of the signature cytokine genes. The correlation of the binding activity of PcG proteins with gene expression is unusual, since they are well known as epigenetic regulators that maintain transcriptional silencing. Here we show that in Th17 cells, the more phenotypically flexible Th lineage, the PcG proteins Mel-18 and less strikingly Ezh2 are associated differentially with the Il17a promoter. Using the RNAi approach, we found that Mel-18 and Ezh2 positively regulate the expression of Il17a and Il17f. The inducible binding of Mel-18 and Ezh2 at the Il17a promoter was dependent on signaling pathways downstream of the TCR. However, a continuous presence of TGF-β, the cytokine that is necessary to maintain Il17a expression, was required to preserve the binding activity of Mel-18, but not of Ezh2, following restimulation. The binding of Mel-18 at the Il17a promoter was correlated with the recruitment of the lineage-specifying transcription factor RORγt. Altogether, our results suggest that in Th17 cells the TCR and polarizing cytokines synergize to modulate the binding activity of Mel-18 at the Il17a promoter, and consequently to facilitate Il17a expression.

DOI: 10.1002/eji.201141620
Version: za2963e q8zaf q8zb4 q8zcd q8zda q8ze8 q8zf8 q8zg1

Similar articles you may find interesting…

  1. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability.

    J Biol Chem 286(32):28511-9 (2011) PMID 21659531

    We demonstrate that Ezh2 can be regulated by the cyclin dependent kinase, CDK1 which phosphorylates Ezh2 at threonines 345 and 487. Consistent with the cell cycle phase that CDK1 exhibits peak activity, Ezh2 phosphorylation is enriched in cells arrested in mitosis compared to S phase. Phosphorylatio...
  2. Phosphorylation of histone H2B serine 32 is linked to cell transformation.

    J Biol Chem 286(30):26628-37 (2011) PMID 21646345 PMCID PMC3143627

    We studied the histone H2B core domain and found that phosphorylation of H2B serine 32 (H2BS32ph) occurs in normal cycling and mitogen-stimulated cells. Notably, this phosphorylation is elevated in skin cancer cell lines and tissues compared with normal counterparts. The JB6 Cl41 mouse skin epiderma...
  3. Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies.

    Oncotarget 2(6):485-90 (2011) PMID 21646683

    Most BCR-ABL1-negative myeloproliferative neoplasms (MPN) carry an activating JAK2 mutation. Approximately 96% of patients with polycythemia vera (PV) harbors the V617F mutation in JAK2 exon 14, whereas the minority of JAK2 (V617F)-negative subjects shows several mutations in exon 12...